Revati Shreeniwas, MD

Medicare standing: 1 flag on the record; Listed below.
Plans that list them: Not verified; Not the same as out of network.
Office: 1

On the public record

Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shreeniwas’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence C50034 · Current

Licensed to practise in California · since 1997 · expires 2028-10-31 · University of Pune, Armed Forces Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Money from drug and device companies

$26,600 in 2025

Sort by

Industry payments by year

2025	1	4	$26,600	$26,600
2024	1	12	$214,800	$214,800
2023	1	11	$472,800	$472,800
2022	1	1	$4,000	$4,000
2021	1	2	$1,400	$1,400
2019	1	1	$6,000	$6,000

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Jazz Pharmaceuticals	None	$26,600	4 payments Consulting · 2025-04-01 · $4,000 Consulting · 2025-02-01 · $9,400 Consulting · 2025-01-06 · $10,400 Consulting · 2025-01-01 · $2,800

See all 4 published payments

Sort by

Every published payment

Jazz Pharmaceuticals	Consulting · 2025-04-01	None	$4,000
Jazz Pharmaceuticals	Consulting · 2025-02-01	None	$9,400
Jazz Pharmaceuticals	Consulting · 2025-01-06	None	$10,400
Jazz Pharmaceuticals	Consulting · 2025-01-01	None	$2,800

See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $214,800

Sort by

Payments by company in 2024

Jazz Pharmaceuticals	Defitelio	$214,800	12 payments Consulting · 2024-12-02 · $23,000 Consulting · 2024-11-01 · $14,400 Consulting · 2024-09-20 · $9,400 Consulting · 2024-08-01 · $28,000 Consulting for Defitelio · 2024-07-01 · $26,400 Consulting for Defitelio · 2024-06-30 · $22,400 Consulting for Defitelio · 2024-05-31 · $19,800 Consulting for Defitelio · 2024-04-01 · $22,000 Consulting for Defitelio · 2024-04-01 · $7,000 Consulting for Defitelio · 2024-03-31 · $4,000 Consulting · 2024-02-29 · $19,400 Consulting · 2024-01-31 · $19,000

2023: $472,800

Sort by

Payments by company in 2023

Jazz Pharmaceuticals	Jzp-441	$472,800	11 payments Consulting for Jzp-441 · 2023-10-01 · $36,400 Consulting for Jzp-441 · 2023-09-30 · $47,800 Consulting for Jzp-150 · 2023-08-31 · $68,000 Consulting for Jzp-441 · 2023-08-01 · $64,400 Consulting for Jzp-441 · 2023-06-23 · $39,200 Consulting for Defitelio · 2023-05-31 · $36,200 Consulting for Jzp-441 · 2023-04-30 · $25,000 Consulting for Jzp-441 · 2023-03-01 · $32,200 Consulting for Jzp-441 · 2023-03-01 · $28,200 Consulting for Jzp-441 · 2023-03-01 · $33,000 Consulting for Defitelio · 2023-02-01 · $62,400

2022: $4,000

Sort by

Payments by company in 2022

Jazz Pharmaceuticals	Defitelio	$4,000	1 payment Consulting for Defitelio · 2022-10-24 · $4,000

2021: $1,400

Sort by

Payments by company in 2021

Jazz Pharmaceuticals	Defitelio	$1,400	2 payments Consulting · 2021-10-18 · $400 Consulting for Defitelio · 2021-08-05 · $1,000

2019: $6,000

Sort by

Payments by company in 2019

Jazz Pharmaceuticals	Sunosi	$6,000	1 payment Consulting for Sunosi · 2019-10-25 · $6,000

Professional record

NPI: 1538295704
Licence: CA C50034California C50034: Current · expires 2028-10-31

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RP1001X (207RP1001X)
Mailing address: 819 Sutter Ave, Palo Alto, CA, 94303
NPI first listed: 2007-02-24
NPI last updated: 2008-04-04

This is when the NPI record was last certified, not a medical board exam.